In severe treatment-resistant depression, long-term data show VNS benefits not only persist for 2 years but also continue to ...
RE104 is a proprietary, potential best-in-class, patented prodrug of 4-OH-DiPT, which is administered via a single subcutaneous injection. Reunion designed RE104 to deliver a short, acute psychoactive ...
Researchers report that vagus nerve stimulation helped many people with long-standing, treatment-resistant depression feel ...
The FDA clears ProlivRx at-home neuromodulation for adjunctive major depressive disorder treatment in adults with inadequate antidepressant response.
Objective To assess prevalence and associated factors of adverse childhood experiences (ACEs) among patients with severe mood disorders (SMDs). Design An institution-based cross-sectional study.
A recent study conducted in Norway suggests that MDMA-assisted therapy may provide lasting relief for individuals suffering ...
What investors want to see is Tonix Pharmaceuticals ( TNXP) move away from a cash-burning R&D company and into having more of a recurring revenue base from its current approved drugs. As of now, the ...
Depression is not only a disorder of mood but also a condition that affects the heart and blood vessels, and can carry ...
Objective This systematic review aims to evaluate the effectiveness of exercise interventions in alleviating depression and ...
Johnson & Johnson’s (J&J) Caplyta (lumateperone) plus antidepressants nearly doubled the likelihood of remission after six ...
The study identifies 28 key criteria for assessing depression apps, emphasizing safety and clinical validity to enhance ...
The press release promoting the study asserts that “universal SEL programs are a sound investment in education systems ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback